Pneumococcal immunisation
Not recruitingStudy on the Safety and Immune Response of a 21-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers
Study on the Safety and Immune Response of a 21-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers
- Disease:Pneumococcal immunisation
- Substances:Pneumococcal oligosaccharide serotype 18C conjugated to CRM197Pneumococcal polysaccharide serotype 1+34
Czechia- Participants:0–17 years · Healthy volunteers
- Substances:Pneumococcal oligosaccharide serotype 18C conjugated to CRM197
- Sponsor:Sanofi Vaccines US Inc.



